Skip to main content
. 2021 Feb 20;47(4):1108–1115. doi: 10.1093/schbul/sbab010

Fig. 4.

Fig. 4.

(a) Mean symptom severity (PANSS total score) for the adherent and non-adherent participants within the simvastatin group Means are estimated by a linear mixed model, with standard error. Data are displayed per visit for the active treatment phase (0–12 mo). Adherence to study medication (simvastatin) was defined as >20% reduction of LDL-cholesterol, compared to baseline, throughout the study. (b) Mean LDL-cholesterol levels for the simvastatin and placebo group. Means are depicted, with standard error. Data are displayed per visit for the active treatment phase (0–12 mo).